-abine |
(see -arabine, -citabine) |
decitabine |
-ac |
Anti-inflammatory agents (acetic acid derivatives) |
bromfenac; dexpemedolac |
-acetam |
See -racetam |
|
-actide |
Synthetic corticotropins |
seractide |
-adol, -aldol- |
Analgesics (mixed opiate receptor agonists/ antagonists) |
tazadolene; spiradolene; levonantradol |
-adox |
Antibacterials (quinoline dioxide derivatives) |
carbadox |
-afenone |
Antiarrhythmics (propafenone derivatives) |
alprafenone; diprafenone |
-afil |
PDE5 inhibitors |
tadalafil |
-aj- |
Antiarrhythmics (ajmaline derivatives) |
lorajmine |
-aldrate |
Antacid aluminum salts |
magaldrate |
-algron |
Alpha1 - and alpha2 - adrenoreceptor agonists |
dabuzalgron |
-alol |
Combined alpha and beta blockers |
labetalol; medroxalol |
-amivir |
(see -vir) |
|
-ampa |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors) |
|
subgroups: |
-ampanel |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); antagonists |
becampanel |
-ampator |
Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); modulators |
forampator |
-andr- |
Androgens |
nandrolone |
-anib |
Angiogenesis inhibitors |
semaxanib |
-anserin |
Serotonin 5-HT2 receptor antagonists |
altanserin; tropanserin; adatanserin |
-antel |
Anthelmintics (undefined group) |
carbantel |
-antrone |
Antineoplastics; anthraquinone derivatives |
pixantrone |
-apsel |
P-selectin antagonists |
torapsel |
-arabine |
Antineoplastics (arabinofuranosyl derivatives) |
fazarabine; fludarabine |
aril-, -aril, -aril- |
Antiviral (arildone derivatives) |
pleconaril; arildone; fosarilate |
-arit |
Antirheumatics (lobenzarit type) |
lobenzarit; clobuzarit |
-arol |
Anticoagulants (dicumarol type) |
dicumarol |
-arone |
Antiarrhythmics |
amiodarone; dronedarone |
-arot- |
Arotinoids |
etarotene; sumarotene; tazarotene |
subgroup: |
-arotene |
Arotinoid derivatives |
bexarotene; linarotene; tazarotene |
arte- |
Antimalarials (artemisin derivatives) |
arteflene |
-ase |
Enzymes |
alglucerase; dornase alfa |
subgroups: |
-dismase |
Enzymes; superoxide dismutase activity (exception: orgotein) |
sudismase |
-teplase |
Enzymes; tissue-type plasminogen activators |
alteplase; duteplase; silteplase |
-uplase |
Enzymes; urokinase-type plasminogen activators |
saruplase; nasaruplase |
-ast |
Antiasthmatics/antiallergics (not acting primarily as antihistamines; leukotriene biosynthesis inhibitors) |
|
subgroups: |
-lukast |
Antiasthmatics/antiallergics; leukotriene receptor antagonists |
cinalukast; pobilukast |
-milast |
Antiasthmatics/antiallergics; type IV phosphodiesterase inhibitors |
piclamilast |
-trodast |
Antiasthmatics/antiallergics; thromboxane A2 receptor antagonists |
seratrodast |
-zolast |
Antiasthmatics/antiallergics; benzoxazole derivatives |
eclazolast; ontazolast |
-tegr- |
Antiasthmatics/antiallergics; integrin antagonists |
valategrast |
-astine |
Antihistaminics (histamine-H1 receptor antagonists) |
ebastine |
-(a)tadine |
Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives |
desloratadine; rupatadine; somantadine |
-atadine |
Tricyclic antiasthmatics |
olopatadine; loratadine |
-axine |
Antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake |
|
subgroup: |
-(f)axine |
|
radafaxine |
-azenil |
Benzodiazepine receptor agonists/antagonists |
bretazenil; flumazenil |
-azepam |
Antianxiety agents (diazepam type) |
lorazepam |
-azepide |
Cholecystokinin receptor antagonists |
devazepide |
-azocine |
Narcotic antagonists/agonists (6,7-benzomorphan derivatives) |
quadazocine; ketazocine |
-azoline |
Antihistamines/local vasoconstrictors (antazoline type) |
antazoline |
-azosin |
Antihypertensives (prazosin type) |
doxazosin |
-bactam |
Beta-lactamase inhibitors |
sulbactam |
-bamate |
Tranquilizers/antiepileptics (propanediol and pentanediol groups) |
meprobamate; felbamate |
-barb, -barb- |
Barbituric acid derivatives |
phenobarbital; secobarbital; eterobarb |
-begron |
Beta 3 adrenoreceptor agonist |
talibegron |
-bendazole |
Anthelmintics (tibendazole type) |
cambendazole |
-berel |
Beta estrogen receptor agonist |
prinaberel |
-bersat |
Anticonvulsants; antimigraine (benzoylamino-benzpyran derivatives) |
carabersat; tidembersat |
bol-, -bol- |
Anabolic steroids |
bolandiol; mibolerone |
-bufen |
Non-steroidal anti-inflammatory agents, fenbufen derivatives |
indobufen |
-bulin |
Antineoplastics (mitotic inhibitors; tubulin binders) |
mivobulin |
-butan |
Antiseptics (dapabutan type) |
dapabutan; lopobutan |
-butazone |
Anti-inflammatory analgesics (phenylbutazone type) |
mofebutazone |
-caine |
Local anesthetics |
dibucaine |
calci-, -calci- |
Vitamin D analogues |
calcipotriene; tacalcitol |
-camra |
Antivirals (intracellular adhesion molecules, icam-1 derivatives) |
tremacamra |
-camsule |
Camphorsulfonic acid derivatives used as UVA sunscreens |
ecamsule |
-casan |
Caspase (interleukin �1b) converting enzyme inhibitors |
pralnacasan |
-caserin |
Serotonin receptor agonists, primarily 5-HT2 |
lorcaserin; vabicaserin |
-castat |
(see -stat) |
|
-carbef |
Antibiotics (carbacephem derivatives) |
loracarbef |
-catib |
Cathespin inhibitors |
balicatib |
-cavir |
(see -vir) |
|
cef- |
Cephalosporins |
cefazolin |
-cept |
Receptor molecules, native or modified ( a preceding infix should designate the target) |
alvircept |
subgroups: |
-co- |
Receptor molecules, native or modified;complement receptors |
mirococept |
-facept |
Receptor molecules, native or modified;lymphocyte function-associated with antigen 3 (LFA) receptor |
alefacept |
-farcept |
Receptor molecules, native or modified; interferon receptors |
pifarcept |
-lefacept |
Receptor molecules, native or modified; lymphocyte function-associated antigen 3 |
alefacept |
-nercept |
Receptor molecules, native or modified; tumor necrosis factor receptors |
lenercept |
-vircept |
Receptor molecules, native or modified; antiviral receptors |
alvircept |
-cet |
Receptors (small molecule) |
|
subgroup: |
-calcet |
Receptors (small molecule); calcium |
tecalcet |
-cetrapib |
Cholesterol ester transfer protein inhibitors |
torcetrapib |
-cic |
Hepatoprotectives (timonacic type) |
limazocic |
-ciclib |
Cyclin dependent kinase inhibitors |
seliciclib |
-ciclovir |
(see -vir) |
|
-cidib |
Cyclin dependent kinase inhibitor |
alvocidib |
-cidin |
Natural antibiotics (undefined group) |
gramicidin |
-ciguat |
Guanaline cyclase activator |
ataciguat; atriciguat |
-cillin |
Penicillins |
ampicillin |
-citabine |
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
gemcitabine; fiacitabine; zalcitabine |
-clidine |
Muscarinic agonists (various indications) |
vedaclidine; talsaclidine |
-clone |
Hypnotics/tranquilizers (zopiclone type) |
pagoclone |
-cog |
Blood coagulation factors |
|
subgroups: |
-eptacog |
Blood coagulation factors; blood coagulation factor VII |
eptacog alfa (activated) |
-nonacog |
Blood coagulation factors; blood coagulation factor IX |
nonacog alfa |
-octocog |
Blood coagulation factors; blood coagulation factor VIII |
moroctocog alfa; octocog alfa |
-cogin |
Blood coagulation cascade inhibitor |
tifacogin |
-conazole |
Systemic antifungals (miconazole type) |
fluconazole; oxiconazole |
-cort- |
Cortisone derivatives |
hydrocortisone |
-coxib |
Cyclooxygenase-2 inhibitors |
celecoxib; parecoxib; valdecoxib |
-cridar |
(see -dar) |
|
-crinat |
Diuretics (ethacrynic acid derivatives) |
brocrinat |
-crine |
Acridine derivatives |
amsacrine; quinacrine |
-cromil |
Antiallergics (cromoglicic acid derivatives) |
nedocromil |
-curium (also -curonium) |
Neuromuscular blocking agents (quaternary ammonium compounds) |
atracurium; alcuronium; pipecuronium |
-cycline |
Antibiotics (tetracycline derivatives) |
minocycline |
-dan |
Positive inotropic agents (pimobendan type) |
prinoxodan; indolidan |
-dapsone |
Antimycobacterials (diaminodiphenylsulfone derivatives) |
acedapsone |
-dar |
Multidrug resistance inhibitors |
|
subgroups: |
-cridar |
Multidrug resistance inhibitors;acridine carboxamide derivatives |
elacridar |
-icodar |
Multidrug resistance inhibitors;pipecolic acid derivatives |
biricodar |
-quidar |
Multidrug resistance inhibitors; quinoline derivatives |
lamiquidar; zozuquidar |
-spodar |
Multidrug resistance inhibitors; ciclosporin D derivatives |
valspodar |
-denoson |
Adenosine A receptor agonists |
tecadenoson; binodenoson |
-dermin |
(see -ermin) |
|
dil-, -dil-, -dil |
Vasodilators (undefined group) |
fostedil |
-dipine |
Phenylpyridine vasodilators (nifedipine type) |
darodipine; felodipine |
-dismase |
(see -ase) |
|
-distim |
(see -stim) |
|
-ditan |
Antimigraine (5-HT1 receptor agonists) |
alniditan |
-dopa |
Dopamine receptor agonists |
levodopa |
-dore |
Dopamine D2D3 receptor modulators |
aplindore fumarate |
-dotin |
Synthetic analogs of the dolastatin series |
tasidotin HCl |
-dralazine |
Antihypertensives (hydrazine-phthalazines) |
hydralazine; endralazine |
-dronate |
Calcium metabolism regulators |
etidronate; tiludronate |
-dutant |
(see -tant) |
|
-ectedin |
Ecteinascodin derivatives |
monectedin |
-ectin |
Antiparasitics (ivermectin type) |
doramectin; moxidectin |
-elestat |
(see -stat) |
|
-elvakin |
(see -kin) |
|
-emcinal |
Erythromycin derivatives lacking antibiotic activity |
mitemcinal |
-entan |
Endothelin receptor antagonists |
bosentan |
-eptacog |
(see -cog) |
|
-eptakin |
(see -kin) |
|
-erg- |
Ergot alkaloid derivatives |
pergolide |
-eridine |
Analgesics (meperidine type) |
anileridine |
-ermin |
Growth factors |
|
subgroups: |
-bermin |
Growth factors; vascular endothelial growth factors |
telbermin |
-dermin |
Growth factors; epidermal growth factors |
murodermin |
-fermin |
Growth factors; fibroblast growth factors |
ersofermin |
-nermin |
Growth factors; tumor necrosis factors |
sonermin; tasonermin |
-plermin |
Growth factors; platelet derived growth factors |
becaplermin |
-sermin |
Growth factors; insulin-like growth factors |
mecasermin |
-termin |
Growth factors; transforming growth factors |
cetermin |
sub subgroups: |
-otermin |
Growth factors; bone morphogenetic proteins |
dibotermin alfa |
estr-, -estr- |
Estrogens |
estrone; fenestrel |
subgroups: |
-estrant |
Estrogen antagonists |
fulvestrant |
-etanide |
Diuretics (piretanide type) |
bumetanide |
-exakin |
(see -kin) |
|
-ezolid |
Oxazolidinone antibacterials |
eperezolid; linezolid |
-farnib |
Farnesyl transferase inhibitor |
tipifarnib |
-fenamate |
"fenamic acid" ester, salt derivatives |
etofenamate |
-fenamic acid |
Anti-inflammatory agents (anthranilic acid derivatives) |
flufenamic acid |
-fenin |
Diagnostic aids ((phenylcarbamoyl)methyl iminodiacetic acid derivatives) |
arclofenin |
-fenine |
Analgesics (fenamic acid subgroup) |
floctafenine |
-fentanil |
Narcotic analgesics (fentanyl derivatives) |
alfentanil; mirfentanil; brifentanil |
-fentrine |
Phosphodiesterase inhibitor |
pumafentrine |
-fermin |
(see -ermin) |
|
-fetamin(e) |
Amfetamine derivatives |
levmetamfetamine |
-fiban |
Fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists) |
lamifiban; tirofiban |
-fibatide |
(see -tide) |
|
-fibrate |
Antihyperlipidemics (clofibrate type) |
bezafibrate |
-filcon |
Hydrophilic contact lens materials |
alphafilcon A; xylofilcon A; mipafilcon A |
-fingol |
Sphingosine derivatives |
cedefingol; safingol |
-flapon |
5-lipoxygenase-activating protein (FLAP) inhibitors |
quiflapon |
-flurane |
General inhalation anesthetics (halogenated alkane derivatives) |
enflurane |
-fo- |
Phosphoro-derivatives |
adefovir |
-focon |
Hydrophobic contact lens materials |
trifocon A; pasifocon B; satafocon A |
-formin |
Hypoglycemics (phenformin type) |
buformin |
-fradil |
Calcium channel blockers acting as vasodilators |
mibefradil |
-fulven |
Antineoplastic, acylfulven derivatives |
viridofulven |
-fungin |
Antifungal antibiotics (undefined group) |
kalafungin |
-fylline |
Theophylline derivatives |
enprofylline; bamifylline; cipamfylline |
-gab- |
Gabamimetics |
fengabine |
gado- |
Gadolinium derivatives (principally for diagnostic use) |
gadodiamide; gadoteridol; gadobenate |
-gapil |
Neuronal apoptosis inhibitors; GAPDH |
omigapil |
-ganan |
Antimicrobial, bactericidal permeability increasing polypeptide |
iseganan; pexiganan |
-gatran |
Thrombin inhibitors (argatroban type) |
efegatran |
-gest- |
Progestins |
megestrol |
-giline |
MAO inhibitors, type B |
selegiline |
-gillin |
Antibiotics (Aspergillus strains) |
mitogillin |
gli- |
Antihyperglycemics |
gliflumide |
-gliptin |
Antihyperglycemics; dipeptidyl aminopeptidase-IV inhibitors |
vildagliptin |
-glitazar |
Antihyperglycemics; PPAR agonists (not thiazolidene derivatives) |
farglitizar |
-glitazone |
Antihyperglycemics; PPST agonists (thiazolidene derivatives) |
ciglitazone; rosiglitazone |
-glumide |
CCK antagonists, antiulcer, anxiolytic agent |
amiglumide; itriglumide |
-golix |
GnRH receptor antagonists (nonpeptide) |
rupugolix |
-gosivir |
(see -vir) |
|
-gramostim |
(see -stim) |
|
-grastim |
(see -stim) |
|
-grel-, -grel |
Platelet aggregation inhibitors (undefined group) |
itazigrel; dimetagrel; furegrelate |
guan- |
Antihypertensives (guanidine derivatives) |
guanoctine |
-ibat |
Ileal bile acid transport inhibitor |
barixibat |
-icam |
Anti-inflammatory agents (isoxicam type) |
enolicam; tenoxicam |
-icodar |
(see -dar) |
|
-ifen(e) |
Antiestrogens of the clomifene and tamoxifen groups |
nitromifene; raloxifene; droloxifene |
-ilide |
Class III antiarrhythmic agents |
ibutilide; risotilide; dofetilide |
-imepodib |
Inosine monophosphate dehydrogenase inhibitors |
merimepodib |
-imex |
Immunostimulants |
forfenimex; roquinimex; ubenimex |
-imibe- |
Antihyperlipidaemics, acyl CoA: cholesterol acyltransferase (ACAT) inhibitors |
eldacimibe; avasimibe; pactimibe |
-imod |
Immunomodulators |
ivarimod; pidotimod |
subgroup: |
-mapimod |
Immunomodulators; mitogen-activated protein (MAP) kinase inhibitors |
dormapimod |
-imus |
Immunosuppressives |
tacrolimus; napirimus; gusperimus; sirolimus |
io- |
Iodine-containing contrast media |
iodamide |
-irudin |
Anticoagulants (hirudin type) |
desirudin |
-isant |
Histamine H3 receptor antagonists |
cipralisant |
-isomide |
Antiarrhythmics (disopyramide derivatives) |
bidisomide |
-ium (also -onium) |
Quaternary ammonium derivatives |
clidinium; disiquonium; polixetonium |
-ixafor |
CXCR4 antagonists |
plerixifor |
-kacin |
Antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin) |
amikacin |
-kalant |
Potassium channel antagonists |
almokalant; terikalant |
-kalim |
Potassium channel agonists |
cromakalim; aprikalim |
-kalner |
Opener of large conductance calcium-activated (maxi-k) K+ channels |
flindokalner |
-kef- |
Enkephalin agonists (various indications) |
metkephamide; casokefamide |
-kin |
Interleukin type substances |
|
subgroups: |
-decakin |
Interleukin type substances; interleukin-10 analogues and derivatives |
ilodecakin |
-dodekin |
Interleukin type substances; interleukin-12 analogues and derivatives |
edodekin alfa |
-elvekin |
Interleukin type substances; interleukin 11 analogues and derivatives |
oprelvekin |
-eptakin |
Interleukin type substances; interleukin 7 analogues and derivatives |
|
-exakin |
Interleukin type substances; interleukin 6 analogues and derivatives |
atexakin alfa |
-leukin |
Interleukin type substances; interleukin 2 analogues and derivatives |
teceleukin; aldesleukin |
-nakin |
Interleukin 1 analogues and derivatives |
|
sub subgroups: |
-onakin |
Interleukin 1 analogues and derivatives; interleukin 1-a analogues and derivatives |
pitonakin |
-benakin |
Interleukin 1 analogues and derivatives; iinterleukin 1-b analogues and derivatives |
mobenakin |
-nonakin |
Interleukin 1 analogues and derivatives; iinterleukin 9 analogues and derivatives |
|
-octakin |
Interleukin 1 analogues and derivatives; iinterleukin 8 analogues and derivatives |
emoctakin |
-penkin |
Interleukin 1 analogues and derivatives; iinterleukin 5 analogues and derivatives |
|
-trakin |
Interleukin 1 analogues and derivatives; iinterleukin 4 analogues and derivatives |
binetrakin |
-kinra |
Interleukin receptor antagonists |
|
subgroup: |
-nakinra |
Interleukin receptor antagonists; interleukin 1 (IL-1) receptor antagonists |
anakinra |
-kiren |
Renin inhibitors |
ditekiren; terlakiren; zankiren |
-lazad |
Lipid peroxidation inhibitors |
tirilazad |
-leptin |
Leptin derivatives |
metreleptin |
-leukin |
(see -kin) |
|
-lind |
Pro-apoptotic cGMP phosphodiesterase inhibitors |
ractalind; dractalind |
subgroup: |
-sulind |
Pro-apoptotic cGMP phosphodiesterase inhibitors; antineoplastics, sulindac metabolites |
exisulind |
-lipim |
Lipoprotein lipase activators |
ibrolipim |
-locib |
Antineoplastics that inhibit the formation of 5-LO, LTB4, LTC4, and thromboxane B2 (TxB2); and Activate PPARg nuclear receptors |
etalocib |
-lubant |
Leukotriene receptor antagonists (treatment of inflammatory skin disorders) |
ticolubant |
-lukast |
(see -ast) |
|
-lutamide |
Antiandrogens |
bicalutamide; flutamide |
-lutril |
Neutral endopeptidase inhibitors possessing additional endothelin converting enzyme inhibitory activity |
daglutril |
-mab |
Monoclonal antibodies |
imciromab; abciximab; capromab; dacliximab; detumomab; enlimomab |
subgroups: |
-axo- |
Monoclonal antibodies; rat-murine hybrid antibodies |
|
-les- |
Monoclonal antibodies; infix for inflammatory/infectious lesions |
|
-toxa- |
Monoclonal antibodies; toxin as a target |
urtoxazumab |
-mantadine, -mantine |
Antivirals/antiparkinsonians (adamantane derivatives) |
rimantadine; dopamantine |
-mastat |
(see -stat) |
|
-meline |
Cholinergic agonists (arecoline derivatives used in treatment of Alzheimer's disease) |
xanomeline |
-melteon |
Selective melatonin receptor agonist |
ramelteon |
-mer |
Polymers |
cadexomer; carbetimer |
-mesine |
Sigma receptor ligands |
igmesine; panamesine |
-mestane |
Antineoplastics (aromatase inhibitors) |
plomestane |
-metacin |
Anti-inflammatory agents (indomethacin type) |
zidometacin |
-micin |
Antibiotics (Micromonospora strains) |
maduramicin; gentamicin |
-monam |
Monobactam antibiotics |
gloximonam; oximonam; tigemonam |
-morelin |
(see -relin) |
|
-moren |
Non-peptidic growth hormone secretagogues |
ibutamoren |
-mostim |
(see -stim) |
|
-motine |
Antivirals (quinoline derivatives) |
famotine |
-moxin |
Monoamine oxidase inhibitors (hydrazine derivatives) |
benmoxin; domoxin |
-mulin |
Antibacterials, pleuromulin derivatives |
retapamulin |
-multin |
Mucosal tolerance inductors |
ismomultin |
-mustine |
Antineoplastics (chloroethylamine derivatives) |
carmustine |
-mycin |
Antibiotics (Streptomyces strains) |
lincomycin |
nab-, -nab- |
Cannabinol derivatives |
nabazenil; dronabinol |
-nakalant |
Mixed sodium/potassium channel blockers |
vernakalant |
-nakin |
(see -kin) |
|
nal- |
Narcotic agonists/antagonists (normorphine type) |
nalmefene |
-navir |
(see -vir) |
|
-nercept |
(see -cept) |
|
-nermin |
(see -ermin) |
|
-nertant |
Neurotensin receptor antagonists |
reminertant |
-nesib |
Kinesin inhibitors |
ispinesib |
-netant |
(see -tant) |
|
-neurin |
Neurotensin receptor antagonists; neurotropins |
abrineurin |
-nicline |
Nicotinic acetylcholine receptor partial agonists/agonists nonsteroidal anti-inflammatory agents (tenidap |
altinicline |
-nidap |
Nonsteroidal anti-inflammatory agents (tenidap type) |
ilonidap; tenidap |
-nidazole |
Antiprotozoal substances (metronidazole type) |
tinidazole |
nifur- |
5-nitrofuran derivatives |
nifuratel; nifuratrone |
-nil |
Benzodiazepine receptor antagonists/agonists |
|
subgroups: |
-punil |
Mitochondrial benzodiazepine receptor (MBR) selective, partial, or inverse agonists (purine derivatives) |
emapunil |
-quinil |
Benzodiazepine receptor agonists, also partial or inverse (quinoline derivatives) |
lirequinil |
-nixin |
Anti-inflammatory agents (anilinonicotinic acid derivatives) |
clonixin |
-nonacog |
(see -cog) |
|
-nonakin |
(see -kin) |
|
-octacog |
(see -cog) |
|
-octakin |
(see -kin) |
|
-olol |
Beta-blockers (propranolol type) |
timolol; atenolol |
-olone |
Steroids (not prednisolone derivatives) |
minaxolone |
-onide |
Topical steroids (acetal derivatives) |
amcinonide |
-opilone |
Epothilone |
filopilone |
-orex |
Anorexiants |
fludorex |
-orphan |
Narcotic antagonists/agonists dextro-(morphinan derivatives) |
methorphan; dextrorphan |
-osuran |
Urotensin receptor antagonists |
palosuran |
-otilate |
Hepatoprotectants, di-isopropyl-1,3-dithiol- malonate derivatives |
mivotilate |
-oxacin |
Antibacterials (quinolone derivatives) |
difloxacin; ciprofloxacin |
-oxan |
Alpha-adrenoceptor antagonists (benzodioxane derivatives) |
imiloxan |
-oxanide |
Antiparasitics (salicylanilide derivatives) |
bromoxanide |
-oxef |
Antibiotics (oxacefalosporanic acid derivatives) |
flomoxef |
-oxetine |
Antidepressants (fluoxetine type) |
dapoxetine; seproxetine |
-pafant |
Platelet-activating factor antagonists |
apafant; dacopafant; tulopafant; lexipafant |
-pamide |
Diuretics (sulfamoylbenzoic acid derivatives) |
alipamide |
-pamil |
Coronary vasodilators (verapamil type) |
tiapamil |
-pamine |
Dopaminergics (butopamine type) |
fosopamine; ibopamine |
-panel |
AMPA receptor antagonists |
fanapanel; irumpanel; talampanel |
-parcil |
Antithrombotics |
beciparcil; iliparcil |
-parcin |
Glycopeptide antibiotics |
avoparcin |
-parin |
Heparin derivatives and low molecular weight (or depolymerized) heparins |
heparin; tinzaparin; dalteparin |
-parinux |
Antithrombotyic indirect selective synthetic factor Xa inhibitors |
fondaparinux |
-paroid |
Antithrombotics (heparinoid type) |
danaparoid; sulparoid |
peg- |
PEGylated compounds |
pegcaristim; pegnartograstim; pegvisomant |
-penem |
Antibacterial antibiotics (carbapenem derivatives) |
imipenem |
-penkin |
(see -kin) |
|
perflu- |
Blood substitutes and/or diagnostics (perfluorochemicals) |
perflubron; perflunafene |
-peridol |
Antipsychotics (haloperidol type) |
haloperidol |
-peridone |
Antipsychotics (risperidone type) |
risperidone; iloperidone; ocaperidone |
-perone |
Antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives) |
duoperone |
-pezil |
Acetylcholinesterase inhibitors used in the treatment of Alzheimer�s disease |
icopezil; donepezil |
-pidem |
Hypnotics/sedatives (zolpidem type) |
zolpidem; alpidem |
-pirdine |
Cognition enhancers |
linopirdine; besipirdine; sibopirdine |
-pirox |
Antimycotics (pyridone derivatives) |
ciclopirox |
-pitant |
(see -tant) |
|
-plact |
Platelet factor 4 analogs and derivatives |
iroplact |
-pladib |
Phospholipase A2 inhibitors |
ecopladib |
-planin |
Antibacterials (Actinoplanes strains) |
mideplanin; ramoplanin; teicoplanin |
-platin |
Antineoplastics (platinum derivatives) |
cisplatin |
-plasninin |
Inhibitors of plasminogen activator inhibitors � type 1 |
tiplasninin |
-plermin |
(see -ermin) |
|
-plestim |
(see -stim) |
|
-plon |
Non-benzodiazepine anxiolytics, sedatives, hypnotics |
ocinaplon; zaleplon |
-poetin |
Erythropoietins |
epoetin alfa; epoetin beta |
-porfin |
Benzoporphyrin derivatives |
verteporfin; temoporfin |
-pramine |
Antidepressants (imipramine type) |
lofepramine |
-prazan |
Acid pump inhibitors, not dependent on acid activation |
omidaprazan |
-prazole |
Antiulcer agents (benzimidazole derivatives) |
omeprazole; disuprazole |
subgroup: |
-maprazole |
Antiulcer agents (benzimidazole derivatives); acid pump inhibitors |
pumaprazole |
pred-, -pred-, -pred |
Prednisone and prednisolone derivatives |
prednicarbate; cloprednol; oxisopred |
-pressin |
Vasoconstrictors (vasopressin derivatives) |
desmopressin |
-pride |
Sulpiride derivatives |
remoxipride; zacopride |
-pril |
Antihypertensives (ACE inhibitors) |
enalapril; temocapril; spirapril |
-prilat |
Antihypertensives (ACE inhibitors) (diacid analogs of the -pril entity) |
enalaprilat; spiraprilat |
-prinim |
Nootropic agents, purine derivatives |
leteprinim |
-prim |
Antibacterials (trimethoprim type) |
ormetoprim |
-prisnil |
Selective progesterone receptor modulators (SPRM) |
asoprisnil |
-pristin |
Antibacterials, pristinamycin derivatives |
quinupristin; efepristin |
-pristone |
Progesterone receptor antagonists |
mifepristone |
-profen |
Anti-inflammatory/analgesic agents (ibuprofen type) |
flurbiprofen |
-prost-, -prost |
Prostaglandin derivatives |
rioprostil; dinoprost |
-protafib |
Protein tyrosine phosphatase 1B inhibitors |
ertiprotafib |
-pultide |
(see -tide) |
|
-proget |
Nonsteroidal ligand for the progesterone receptor |
tanaproget |
-queside |
Cholesterol sequestrants (glycosides) |
pamaqueside |
-racetam |
Nootropes (piracetam type) |
piracetam |
-racil |
Uracil type antineoplastics |
eniluracil; gemeracil; oteracil |
-relin |
Prehormones or hormone-release stimulating peptides subgroups: |
nafarelin |
subgroups: |
-morelin |
Growth hormone-release stimulating peptides |
dumorelin |
-tirelin |
Thyrotropin releasing hormone analogues |
protirelin |
-relix |
Hormone-release inhibiting peptides aldosterone antagonists (spironolactone type) |
detirelix |
-renone |
Aldosterone antagonists (spironolactone type) |
canrenone |
-restat |
(see -stat) |
|
-retin-, -retin |
Retinol derivatives |
etretinate; pelretin |
-rev |
Therapeutic virus |
|
subgroup: |
-tucirev |
Therapeutic virus; tumoricidal |
lontucirev |
-ribine |
Ribofuranil derivatives (pyrazofurin type) |
loxoribine |
rifa- |
Antibiotics (rifamycin derivatives) |
rifapentine; rifampin |
-rinone |
Cardiotonics (amrinone type) |
milrinone |
-rozole |
Aromatase inhibitors (imidazole/triazole derivatives) |
letrozole; fadrozole; vorozole |
-rsen |
Antisense oligonucleotides |
alicaforsen |
-rubicin |
Antineoplastic antibiotics (daunorubicin type) |
esorubicin; idarubicin |
sal-, -sal-, -sal |
Anti-inflammatory agents (salicylic acid derivatives) |
mesalamine; diflunisal; balsalazide |
-sartan |
Angiotensin II receptor antagonists |
losartan; eprosartan |
-semide |
Diuretics (furosemide type) |
azosemide |
-sermin |
(see -ermin) |
|
-serod |
Serotonin receptor antagonists and partial agonists |
piboserod |
-serpine |
Rauwolfia alkaloid derivatives |
reserpine |
-setron |
Serotonin 5-HT3 antagonists |
ondansetron; granisetron; lurosetron |
-siban |
Oxytocin antagonists |
barusiban |
-sidomine |
Antianginals (sydnone derivatives) |
pirsidomine; molsidomine; linsidomine |
som- |
Growth hormone derivatives |
somatrem; somatropin |
subgroups: |
som- -bove |
Growth hormone derivatives; bovine somatotropin derivatives |
sometribove |
som- -por |
Growth hormone derivatives; porcine somatotropin derivatives |
sometripor; somagrepor |
-sonan |
5-HT1B receptor antagonists |
elzasonan |
-spirone |
Anxiolytics (buspirone type) |
zalospirone; tiospirone |
-spodar |
(see -dar) |
|
-sporin |
Immunosuppressants (cyclosporine type) |
geclesporin; oxeclosporin |
-stat-, -stat |
Enzyme inhibitors |
|
subgroups: |
-castat |
Enzyme inhibitors; dopamine beta-hydrolase (DBH) inhibitors |
nepicastat |
-elestat |
Enzyme inhibitors; elastase inhibitors |
sivelestat |
-inostat |
Enzyme inhibitors; inhibitors of histone deacetylase |
dacinostat |
-mastat |
Enzyme inhibitors; antineoplastics (matrix metalloproteinase inhibitors) |
batimastat |
-(a)mostat |
Enzyme inhibitors; proteolytic enzyme inhibitors |
nafamostat |
-restat-, -restat |
Aldose-reductase inhibitors |
ponalrestat; tolrestat |
-vastatin |
Antihyperlipidemics (HMG-CoA inhibitors) |
atorvastatin; lovastatin; pravastatin |
-urestat |
Urease inhibitor |
benurestat |
-stat- |
Renal dehydropeptidase inhibitor |
cilastatin |
-stat- |
Pepsin inhibitor |
pepstatin |
-statin |
Renal dehydropeptidase inhibitor pepsin inhibitor |
cilastatin; pepstatin |
-ster- |
Steroids (androgens, anabolics) |
testosterone |
-steride |
Testosterone reductase inhibitors |
epristeride; fenasteride |
-stigmine |
Cholinesterase inhibitors (physostigmine type) |
quilostigmine; teserstigmine |
-stim |
Colony-stimulating factors |
|
subgroups: |
-distim |
Colony-stimulating factors; conjugates of two different types of colony-stimulating factors |
milodistim |
-gramostim |
Colony-stimulating factors; granulocyte macrophage colony- stimulating factors (GM-CSF) |
molgramostim; regramostim; sargramostim; ecogramostim |
-grastim |
Colony-stimulating factors; granulocyte colony-stimulating factors (G-CSF) |
filgrastim; lenograstim |
-mostim |
Colony-stimulating factors; macrophage colony-stimulating factors (M-CSF) |
mirimostim |
-plestim |
Colony-stimulating factors; interleukin 3 derivatives; pleiotropic colony-stimulating factors |
daniplestim |
-stinel |
NMDA receptor antagonists (glycine recognition site) |
licostinel |
-sulam |
Antineoplastics, apoptosis inducing sulfonamide |
indisulam |
sulfa- |
Antimicrobials (sulfonamides derivatives) |
sulfasalazine |
-sulfan |
Antineoplastics, alkylating agents (methanesulfonate derivatives) |
busulfan |
-sulind |
(see -lind) |
|
-tant |
Tachykinin (neurokinin) receptor antagonists |
|
subgroups: |
-dutant |
Tachykinin (neurokinin) receptor antagonists; NK2 receptor antagonists |
saredutant |
-netant |
Tachykinin (neurokinin) receptor antagonists; NK3 receptor antagonists |
osanetant |
-pitant |
Tachykinin (neurokinin) receptor antagonists; NK1 receptor antagonists |
dapitant; zinapitant; lanepitant |
-tapide |
Microsomal triglyceride transfer protein (MTP) inhibitors |
implitapide |
-taxel |
Antineoplastics, taxane derivatives |
paclitaxel |
-tecan |
Antineoplastics (camptothecine derivatives) |
topotecan; irinotecan |
-tecarin |
Antineoplastics (rebeccamycin derivatives) |
becatecarin |
-tepa |
Antineoplastics (thiotepa derivatives) |
azetepa |
-teplase |
(see -ase) |
|
-termin |
(see -ermin) |
|
-terol |
Bronchodilators (phenethylamine derivatives) |
albuterol |
-tesind |
Thymidilate synthetase inhibitors (benzindole derivatives) |
metesind |
-texafin |
Texaphryn derivatives |
motexafin |
-thiazide |
Diuretics (thiazide derivatives) |
chlorothiazide |
-tiapine |
Antipsychotics (dibenzothiazepine derivatives) |
quitiapine |
-tiazem |
Calcium channel blockers (diltiazem type) |
diltiazem; clentiazem; iprotiazem |
-tibant |
Antiasthmatics (bradykinin antagonists) |
icatibant |
-tide |
Peptides and glycopeptides |
octreotide |
subgroups: |
-fibatide |
Peptides and glycopeptides; platelet aggregation inhibitors (glycoprotein IIb/IIIa receptor antagonists) |
eptifibatide |
-pultide |
Peptides and glycopeptides; peptides used as pulmonary surfactants |
sinapultide |
-tidine |
H2-receptor antagonists (cimetidine type) |
lupitidine; ranitidine; donetidine |
-tinib |
Tyrosine kinase inhibitors |
canertinib; imatinib; mubritinib |
-tirelin |
(see -relin) |
|
-tirome |
Antihyperlidaemic, thyromimetic derivatives |
anitirome; axitirome |
-tocin |
Oxytocin derivatives |
oxytocin |
-toclax |
Antineoplastic, BLC-2 inhibitor |
obatoclax |
-toin |
Antiepileptics (hydantoin derivatives) |
albutoin |
-toran |
TLR4 receptor antagonists |
eritoran |
-tox(a)- |
Toxins |
urtoxazumab |
-traposin |
AP2 inhibitors |
seltraposin |
-trexate |
Antimetabolites (folic acid derivatives) |
methotrexate |
-trexed |
Antineoplastic thymidylate synthetase inhibitors |
pemetrexed; ralitrexed; nolatrexed |
-tricin |
Antibiotics (polyene derivatives) |
mepartricin |
-tril, -trilat |
Endopeptidase inhibitors |
candoxatril; candoxatrilat |
-triptan |
Antimigraine agents (5-HT1 receptor agonists) |
naratriptan; oxitriptan; sumatriptan |
-triptyline |
Antidepressants (dibenzo[a,d]cycloheptane derivatives) |
amitriptyline |
-troban |
Antithrombotics (thromboxane A2 receptor antagonists) |
daltroban; sulotroban |
-trodast |
(see -ast) |
|
-troline |
Antipsychotics (dopamine D2 antagonists) |
carvotroline; gevotroline |
-trombopag |
Thrombopoetin agonists |
eltrombopag |
trop-, -trop- |
Atropine derivatives |
benztropine |
-uclin |
Mucosal tolerance inhibitors |
|
-uplase |
(see -ase) |
|
-uracil |
Uracil derivatives used as thyroid antagonists and as antineoplastics |
fluorouracil |
-uridine |
Antivirals; antineoplastics (uridine derivatives) |
idoxuridine |
-vaptan |
Vasopressin receptor antagonists |
conivaptan; relcovaptan |
-vastatin |
(see -stat) |
|
-verine |
Spasmolytic agents (papaverine type) |
mebeverine |
vin-, -vin- |
Vinca alkaloids |
vinepidine; apovincamine |
vir-, -vir-, -vir |
Antiviral substances (undefined group) |
ganciclovir; enviradine; viroxime; alvircept; delavirdine |
subgroups: |
-amivir |
Antiviral substances; neuraminidase inhibitors |
zanamivir |
-cavir |
Antiviral substances; carbocyclic nucleosides |
lobucavir |
-cyclovir |
Antiviral substances; (acyclovir type) |
acyclovir |
-ciclovir |
Antiviral substances; (acyclovir type) |
desciclovir; famciclovir; penciclovir |
-gosivir |
Antiviral substances; glucosidase inhibitor |
celgosivir |
-navir |
Antiviral substances; HIV protease inhibitors (saquinavir type) |
droxinavir; indinavir; ritonavir |
-virdine |
Antiviral substances; (non-nucleoside reverse transcriptase inhibitors; pyridine derivatives) |
atevirdine; delevirdine |
-virenz |
Antivirals (non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives) |
efavirenz |
-virsen |
Antivirals (antisense) |
afovirsen; fomivirsen; trecovirsen |
-vircept |
(see -cept) |
|
-virdine |
(see -vir) |
|
-virenz |
(see -vir) |
|
-virimat |
Antiviral, disrupts viral maturation |
bevirimat |
-viroc |
CCR5 antagonists |
maraviroc |
subgroup: |
-criviroc |
CCR5 antagonists, immunomodulators |
ancriviroc |
-vudine |
Antineoplastics; antivirals (zidovudine group) (exception: edoxudine) |
stavudine; lamivudine; alovudine |
-xaban |
Anticoagulant (Factor Xa inhibitor) |
tamixaban |
-xanox |
Antiallergic respiratory tract drugs (xanoxic acid derivatives) |
tixanox |
-(x)antrone |
Antineoplastics, mitoxantrone derivatives aza-anthracenedione class of antitumor agents |
pixantrone |
-zolamide |
Carbonic anhydrase inhibitors |
brinzolamide; dorzolamide; sezolamide |
-zolast |
(see -ast) |
|
-zomib |
Proteozome inhibitors |
bortezomib |
-zotan |
5-HT1A receptor agonists/antagonists acting primarily as neuroprotectors |
robalzotan; sarizotan; ibalzotan; lecozotan |